The 3-O-nicotinoyl substituent (Figure 1c) demonstrated potent efficacy, with IC 50 values of 18.68 M, 13.16 M, and 7.48 M against HBsAg secretion, HBeAg (Hepatitis B e Antigen) secretion, and HBV (Hepatitis B Virus) DNA replication, respectively (Wang et al., 2012b)
Over 100 published preclinical studies have demonstrated protective and reparative effects of BPC-157 across tendon, muscle, bone, and gastrointestinal tissue
In dextran sulfate sodium colitis, liraglutide attenuates tight junction gene expression in the cecum Given that LPS, a component of Gram-negative bacteria such as E
Regulatory Compliance & Standards Framework 5.7